GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for aspartate carbamoyltransferase (B2A2U7)

Analyse AlphaFold monomer V2.0 prediction for aspartate carbamoyltransferase (B2A2U7) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B2A2U7
Type
protein
Length
313 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xbDA05C32aD6eE153C8C5A78dfa48d7Ba25694fea
Molecule
Aspartate carbamoyltransferase
UniProt
B2A2U7
Pockets
1 · best druggability 0.65

Structure

1 distinct chain · 43% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAspartate carbamoyltransferaseprotein31343% helix, 16% strandB2A2U7

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11740.650.8532empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.